<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Virtually all reports coincide that morbidity and mortality due to COVID-19 infection are increased by the presence of diabetes. In the series published by New York city hospitals, diabetes was more prevalent in those patients requiring admission (31.8%) than in those not requiring admission (5.4%) [
 <xref ref-type="bibr" rid="CR8">8</xref>] (Fig. 
 <xref rid="Fig2" ref-type="fig">2</xref>). Indeed, diabetes was also reported as an important risk factor for worse disease modality and excessive mortality while the occurrence of the Influenza A (H1N1) pandemic, SARS-CoV and MERSCoV outbreaks [
 <xref ref-type="bibr" rid="CR4">4</xref>]. Influenza A (H1N1) pandemic, tripled the risk of hospitalization and quadrupled the risk of intensive care unit (ICU) admission when diabetes was present [
 <xref ref-type="bibr" rid="CR3">3</xref>]. Consistent with that, data from China found that diabetes accounted for 8%–16% of hospitalized patients [
 <xref ref-type="bibr" rid="CR10">10</xref>, 
 <xref ref-type="bibr" rid="CR11">11</xref>], being diabetes prevalence across China around 5% [
 <xref ref-type="bibr" rid="CR12">12</xref>].
</p>
